Reconstruction of Protein-Protein Interaction Network of Insulin Signaling in Homo Sapiens by Durmuş Tekir, Saliha et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 690925, 7 pages
doi:10.1155/2010/690925
Research Article
Reconstruction of Protein-Protein InteractionNetwork of
InsulinSignaling inHomoSapiens
SalihaDurmus ¸ Tekir, Pelin ¨ Umit, AysunErenToku,and Kutlu ¨ O. ¨ Ulgen
Department of Chemical Engineering, Bo˘ gazic ¸i University, 34342 Bebek-˙ Istanbul, Turkey
Correspondence should be addressed to Saliha Durmus ¸T e k i r ,saliha.durmus@boun.edu.tr
Received 21 April 2010; Revised 22 July 2010; Accepted 27 October 2010
Academic Editor: Sorin Draghici
Copyright © 2010 Saliha Durmus ¸ Tekir et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Diabetes is one of the most prevalent diseases in the world. Type 1 diabetes is characterized by the failure of synthesizing and
secreting of insulin because of destroyed pancreatic β-cells. Type 2 diabetes, on the other hand, is described by the decreased
synthesisandsecretion ofinsulinbecause ofthedefect inpancreatic β-cells aswellasbythefailureofrespondingto insulinbecause
ofmalfunctioningofinsulinsignaling.In order to understand the signalingmechanismsofresponding to insulin,itis necessary to
identify all components in the insulin signalingnetwork. Here, an interaction network consistingof proteins that have statistically
highprobability ofbeing biologically related to insulinsignalingin Homo sapiens was reconstructed by integrating Gene Ontology
(GO) annotations and interactome data. Furthermore, within this reconstructed network, interacting proteins which mediate the
signal from insulin hormone to glucose transportation were identiﬁed using linear paths. The identiﬁcation of key components
functioning in insulin action on glucose metabolism is crucial for the eﬀorts of preventing and treating type 2 diabetes mellitus.
1.Introduction
Signaling provides the communication of living cells by pro-
cessing biological information. Mammalian cells integrate
information from complex intracellular signaling pathways
tomakedecisionsinresponse tochangesin theenvironment.
Usingsystematicgenome-wideandpathwayspeciﬁcprotein-
protein interaction screens, a framework of the intercon-
nectivity of a large number of human proteins, including
therapeutically relevant disease-associated proteins has been
generated by these pathways. Recent developments in these
protein-protein interaction networks have increased the
understanding of the mechanisms of diseases with identiﬁ-
cation of drug targets and adaptation of living cells to the
environment [1–5].
In mammalian cells, the balance between hepatic glucose
production and glucose utilization by the tissues, such
as liver, adipose, muscle, brain, and kidney provides the
glucose homeostasis. In healthy individuals, the increased
blood glucose levels result in secretion of insulin from β-
cells of the pancreas. Insulin triggers the transportation of
glucoseinto peripheraltissuesbyglucosetransporter GLUT4
inhibiting hepatic glucose production [6]. By the stim-
ulation of insulin (INS) hormone, the insulin receptor
(INSR) phosphorylates insulin receptor substrate (IRS)
proteins that activate two main signaling pathways. The
phosphatidylinositol 3-kinase (PI3K)-AKT/protein kinase B
(PKB) pathway is responsible for the metabolic actions
of the insulin such as glucose uptake, glycogen synthesis,
gene expression, and protein synthesis. The Ras-mitogen
activated protein kinase (MAPK) pathway controls cell
growth and diﬀerentiation by regulating expression of some
genes and cooperating with PI3K pathway [7, 8]. Defects
in insulin signaling pathways may decrease the ability of
peripheral tissues to respond to insulin (insulin resistance)
causing type 2 diabetes. Beside its primary role in glucose
homeostasis, insulin signaling mechanism also regulates
ion and amino acid transport, lipid metabolism, glycogen
synthesis, gene transcription and mRNA turnover, protein
synthesis and degradation, and DNA synthesis by a complex,
highly integrated network activated by the insulin receptor
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Most of research published so far reports experimental
andcomputationalworktodeciphersmall-scale mechanisms
around key proteins in insulin metabolism [6, 10–13].
However, it is very important to capture the global picture
of insulin signaling in order to understand the mechanisms
underlying diabetes with crosstalks between other signaling
networks. This need motivated us for the reconstruction
of insulin signaling network in Homo sapiens with the aim
of identiﬁcation of all known components together with
new candidate proteins of insulin signaling. In this study,
a computational framework integrating interactome data
with GO annotations was used to build large scale protein
interactionnetworkwhich iscomposedofcandidateproteins
for insulin signaling in Homo sapiens.T h er e c o n s t r u c t e d
insulin signaling network was decomposed into linear paths
resulting in glucose transportation to be able to identify
the proteins functioning in this metabolic action of insulin.
The topology of the reconstructed insulin signaling network
governing glucose transportation was then analyzed to
determine whether the network properties are biologically
feasible or not, and to obtain detailed information about the
signaling mechanisms. Moreover, graph theoretic analysis
gives the proteins that are well or poorly connected in the
interaction network. This study provides a comprehensive
insulin signaling network with indication of keycomponents
which will facilitate a deeper understanding of underlying
mechanisms of insulin-resistant states and pathophysiology
of insulin deﬁciency.
2.Materialsand Methods
2.1. Network Reconstruction by GO Annotations. Figure 1
represents an overview of the computational approach inte-
grating Gene Ontology (GO) annotations and interactome
data for the reconstruction of a protein interaction network
which was used to predict candidate proteins in insulin
signaling in human. All known interacting human proteins
obtained from BioGRID version 2.0.61 release were used as
inputs to the algorithm. BioGRID (The Biological General
Repository for Interaction Datasets) uses the results of high-
throughput experiments and conventional studies [14]. The
GO annotations (in terms of cellular component, molecular
function and biological process) of the core proteins
that are known to have certain functions in the insulin
signaling were collected (http://www.ebi.ac.uk/QuickGO/)
to form an annotation collection table (see Supplementary
material available on line at doi:10.1155/2010/690925). The
relevance of the human proteins to the insulin signaling was
tested by employing this annotation collection table. The
proteins with all three GO terms matching to those in the
annotationcollectiontablewere addedto thenetwork. Thus,
a high probability of having role in the insulin-interaction
network is ensured for these proteins. In the second step,
the interaction data among these proteins were obtained
from BioGRID version 2.0.61 release, and the network
architecture was constructed.
2.2. Network Decomposition Analysis. Network decomposi-
tion analysis is based on the decomposition of a protein
interaction network into linear paths starting from inputs
(ligands) and extending to outputs (cellular responses). In
the reconstructed insulin signaling network, the linear paths
from the insulin receptor to the glucose transporter GLUT4
were found by the NetSearch algorithm [15], and the speciﬁc
part of the protein network governing insulin action on
glucose metabolism was identiﬁed. The participation of the
proteins in linear paths can be considered as an indication of
their importance in the signal transduction, since any state
of the signaling network is a combination of the linear paths
[16].Therefore, theparticipationpercentagesofeach protein
in linear paths of thereconstructed insulin signaling network
were calculated to get an insight on the roles of the proteins
in the signal transduction from INS to GLUT4.
2.3. Graph Theoretic Analysis. The topology of the recon-
structed protein-protein interaction network functioning in
glucose transportation was determined by graph theoretic
analysis [17–19] based on the properties, such as the
degree (connectivity) of nodes, the number of hubs (highly
connected nodes), and the shortest path lengths between
indirectly connected nodes, network diameter and mean
path length. The graphproperties of the network were found
using Network Analyzer plugin (ver. 2.6.1) of Cytoscape
(ver. 2.6.3). The input to the calculation is the list of binary
interacting proteins. Observing the connectivity distribution
oftheproteinsallowsustoidentifyhighlyconnectedproteins
which participate in signiﬁcant numbers of interactions
and play critical roles in the organization of the cellular
protein interaction network. Mean path length and network
diameter are calculated as the average and the maximum of
the shortest path lengths, respectively.
3.Resultsand Discussion
In the present study, the protein-protein interaction network
of insulin signaling was reconstructed in Homo sapiens
with special emphasis onglucosetransportation mechanism.
During the reconstruction of a protein interaction network,
the main problem is the existence of false positives and false
negatives in the available interaction data obtained mostly
by high-throughput screens [20–22]. Several approaches
have been performed to improve the quality of the data by
integrating diﬀerent biological features, including GO anno-
tations [23–27]. Compared to metabolic and regulatory net-
works, the reconstruction and analysis of signaling networks
are very limited. The previous signaling network reconstruc-
tion methods are focused on integration of protein-protein
interaction data with microarray gene expression proﬁles
[15, 28–30] or a detailed literature survey on published
knowledge [2, 3]. Here, we used a computational framework
integrating interactome data with GO annotations.
3.1. Reconstruction of Insulin Signaling Networkin H. Sapiens.
30proteinsrelatedtohumaninsulinsignalingwereidentiﬁed
by the literature information [6, 7, 12, 31–35]a n dG Oa n -
notations (Table 1). Through the literature search only ex-
perimental cases were investigated, and the proteins that areJournal of Biomedicine and Biotechnology 3
Table 1: Core proteins of the insulin signaling network.
Protein Symbol Protein Name
AHSG Alpha-2-HS-glycoprotein
AKT1 RAC-alpha serine/threonine-protein kinase
AKT2 RAC-beta serine/threonine-protein kinase
AP3S1 AP-3 complex subunit sigma-1
BAIAP2 Brain-speciﬁc angiogenesis inhibitor 1-associated protein 2
BCAR1 Breast cancer antiestrogen resistance protein 1
CILP Cartilage intermediate layer protein 1
ENPP1 Ectonucleotide pyrophosphatase/phosphodiesterase family member 1
FOXO4 Forkhead box protein O4
GAB1 GRB2-associated-binding protein 1
GRB2 Growth factor receptor-bound protein 2
GRB10 Growth factor receptor-bound protein 10
IGFBP5 Insulin-like growth factor-binding protein 5
IGF1 Insulin-like growth factor IA
IGF1R Insulin-like growth factor 1 receptor
IGF2 Insulin-like growth factor II
IGF2R Insulin-like growth factor type 2 receptor
INS Insulin
INSR Insulin receptor
IRS1 Insulin-receptor substrate 1
IRS2 Insulin-receptor substrate 2
PDPK1 3-phosphoinositide-dependent protein kinase 1
PHIP PH-interacting protein
PIK3R1 Phosphatidylinositol 3-kinase regulatory subunit alpha
PIK3R3 Phosphatidylinositol3-kinase regulatory subunit gamma
SIK2 Salt inducible protein kinase 2
SLC2A4 (GLUT4) Solute carrier family 2, facilitated glucose transporter member 4
SOCS1 Suppressor of cytokine signaling1
SORBS1 Sorbin and SH3 domain-containingprotein 1
TSC2 Tuberin
reported as functioning in insulin signaling mechanisms in
human were considered as the core proteins. In addition
to that, some core proteins were collected via their GO
function and process terms which indicate insulin signaling
explicitly. Therefore, each of these proteins is known to be
essential for insulin actions. For instance, the binding of
insulin receptor substrate-1 (IRS1) to the phosphorylated
insulin receptor (INSR) leads to the activation of phos-
phatidylinositol 3-kinase (PI3K) whose regulatory subunits
(PIK3R1and PIK3R3)playpivotalrolesin themetabolicand
mitogenic actions of insulin. AKT1 plays an important role
in GLUT4 translocation via phosphorylating and regulating
components of GLUT4 complex [7, 36]. By reconstructing
the protein-protein interaction network this study unravels
the mechanisms around these insulin signaling proteins.
8211 interacting human proteins obtained from BioGrid
2.0.61 were tested through the GO annotations of the core
proteins. If thereis at leastone annotation for each of theGO
terms (component, function, and process) that are included
in the annotation collection table, the corresponding protein
was added to the network. Consequently, 6248 proteins
passed this selection criterion increasing their probability
to have function in insulin signal transduction. However,
only 3588 of these proteins have interactome data, and of
these, 365 proteins cannot be included into the network as
the GO terms of their interacting partners do not coincide
with those in the annotation collection table. Eventually,
an interaction network of 3223 nodes and 10537 edges is
obtained for insulin signaling. When the isolated smaller
parts are removed the resulting protein-protein interaction
network consists of 3056 proteins and 10401 interactions
among them (see Supplementary material). Two of the
core proteins CILP and PHIP are not included in the
reconstructed network, since CILP has no interaction data,
and PHIP’s interacting partners does not fulﬁll the selection
criterion based on GO annotations.
3.2. Network Decomposition Analysis. In a protein interac-
tion network, a signaling pathway for a speciﬁc signaling
output can be identiﬁed using linear paths starting from4 Journal of Biomedicine and Biotechnology
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Figure 1: Computational approach in protein interaction network
reconstruction.
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Figure 2: Degree (connectivity) distribution of the nodes in the
reconstructed insulin signalingprotein interaction network.
membrane-bound receptors and ending at that particular
cellular response [23]. The linear paths of the reconstructed
network (3056 proteins and 10401 interactions) were found
using NetSearch algorithm of Steﬀen and coworkers [15].
INSR (insulin receptor) and GLUT4 (glucose transporter
4) proteins were used as the input and the output of the
Table 2: Linear paths from INSR to GLUT4.
Maximum path
length
Number of
linear paths
Number of
proteins
Number of
core proteins
47 1 4 2
5 251 105 7
6 7176 498 17
7 185,528 1157 18
Table 3: The top 10 proteins that participate in 7176 linear paths.
Proteins Participation (%)
AR 32.78
SMAD2 17.46
MDM2 14.24
NR3C1 12.88
MAPK1 11.23
PML 10.66
HDAC1 10.27
UBE2I 9.03
TP53 8.82
JAK2 8.08
signaling network, respectively, for the identiﬁcation of the
proteins that have roles in the insulin signal transduction
triggered by binding of insulin to its receptor and ending
with metabolic action of glucose transportation.
The shortest path length between INSR and GLUT4 was
foundas4,since theshortest 7linearpathsinclude5proteins
connected linearly by 4 interactions. In order to determine
the optimum path length for the identiﬁcation of the linear
paths functioning speciﬁcally in glucose transportation,
the paths were searched by increasing the maximum path
length by one each time (Table 2). The number of core
proteins and the interacting proteins included in the linear
paths were investigated to determine the critical path length
and participating proteins that have roles in glucose trans-
portation response of the signaling network. Between INSR
and GLUT4, a path length of 6 resulting in 7176 linear paths
was chosen to be optimum, as it provides a balance between
smaller path length and participating core proteins. The
criterion of small path length is reasonable, since signaling
mechanisms are known to give such responses very quickly
[37].Increasing themaximum pathlengthfrom6 to7causes
the number of the core proteins that participate in the linear
paths to increase only by one, from 17 to 18, despite a nearly
two fold increase in the number of interacting proteins.
Increasing thepathlengthmore than6would resultinnearly
same signaling mechanisms around these 17 core proteins
with longer paths covering more proteins in the insulin
signaling network. Therefore, these 498 proteins and 2887
interactions (see Supplementary material) that function in
the linear paths at a path length of 6 constitute the insulin
signaling pathway having roles in glucose translocation.
Bottleneck proteins are known as the key connectors
that are central to many shortest paths in an interaction
network [38]. To identify the bottlenecks in the signalJournal of Biomedicine and Biotechnology 5
transduction from INSR to GLUT4, the percentage of each
protein contributing to 7176 linear paths were calculated.
INSR, GLUT4 and DAXX (death domain-associated protein
6) participate in all the linear paths since they are the input,
the output, and the unique protein that connects GLUT4
to the network as its interacting partner, respectively. 10
following proteins with the highest participation in these
linear paths (Table 3)s h o u l db ei n v e s t i g a t e dw i t hs p e c i a l
care owing to their critical roles in transducing the signal
from INSR to GLUT4. These proteins are highly encoun-
tered in linear paths as many are bound to the input or
output proteins. SMAD2 (mothers against decapentaplegic
homolog 2), MAPK1 (mitogen activated protein kinase
1), and JAK2 (tyrosine protein kinase JAK2) interact with
INSRin the reconstructed network. AR (androgenreceptor),
MDM2 (E3 ubiquitin protein ligase Mdm2), NR3C1 (glu-
cocorticoid receptor), UBE2I (SUMO-conjugating enzyme
UBC9), HDAC1(histone deacetylase 1),and PML (probable
transcription factor PML) interact with DAXX which is
the only protein having an interaction with GLUT4 in the
network. On the other hand, TP53 (tumor protein p53)
was also found to be a bottleneck in the PPI network,
since it has interactions with other bottleneck proteins such
as MAPK1, MDM2, UBE2I, HDAC1, PML, and NR3C1.
Since these bottleneck proteins control most of the signal
transduction from insulin to the glucosetransporter protein,
their mutations may cause glucose transportation system to
fail resulting in insulin resistance.
The most promising result of architecture of the recon-
structed network is about DAXX protein, since it connects
GLUT4 to the network. Although its physical interaction
with GLUT4 was reported [41], its functional roles in
insulin signaling mechanism remain elusive except very few
studies [42]. Therefore, the ending part of the interaction
network functioning through glucose transportation should
be investigated thoroughly to discover the eﬀects of DAXX
on GLUT4.
3.3. Graph Theoretic Analysis. The reconstructed insulin sig-
naling network was represented by an undirected interaction
graph with 498 nodes and 2887 edges. The topological
analysis was performed using Network analyzer plugin
of Cytoscape. The network diameter and the mean path
length were found as 5 and 2.9, respectively, indicating the
small-world topology. A comparative analysis of the graph
theoretic properties of several protein interaction networks
(Table 4) similarly reveals the small-world architecture. The
comparison of the number of nodes and edges of the present
network with those of the other PPI networks indicates
that the reconstructed insulin signaling network is highly
connected, that is, its average connectivity is 11.6. The small
network diameter and the low mean path length result
from this architecture since any two nodes in the network
are connected by shorter paths through high number of
neighbouring proteins. The connectivity (k,t h en u m b e ro f
linkspernode)distributionofthenodesin thereconstructed
graph was found as scale-free (Figure 2) following nearly a
power law model (P(k) ≈ k−γ γ = 1.53 R2 = 0.83). Having
small-world properties with scale-free topology is a general
characteristic of complex biological networks [43–47]. The
node of GLUT4 with onlyone edgewas excludedin theinner
diagram of Figure 2 since it is an outlier point.
The hubs of the insulin signaling network were deter-
mined as GRB2 (growth factor receptor bound protein 2),
HDAC1, AR, and TP53 having connectivity values of 88, 84,
83 and 74, respectively. GRB2 has a vital role in signaling
by receptor protein tyrosine kinases, where its SH2 and SH3
domains bind to the receptors and eﬀectors and it functions
in the insulin signaling through lots of proteins including
IRS1 [34, 35]. It was reported that HDAC inhibition in
human primary myotubes increases endogenous GLUT4
gene expression [48]. Investigating all HDAC proteins in the
r e c o n s t r u c t e dn e t w o r k( H D A C 1 ,2 ,3 ,4 ,5 ,9 )m a yp r o v i d e
potential drug targets for the treatment and management of
insulin resistance and type 2 diabetes. Similar to HDAC1,
TP53 has a repressive eﬀect on transcriptional activity of
the GLUT4 gene promoters. Mutations within its DNA-
binding domain were found to impair this repressive eﬀect
resulting in increased glucose metabolism and cell energy
supply facilitating tumor growth [49]. AR functions mainly
as a ligand-activated transcription factor. Besides, it was
reported to induce the rapid activation of kinase signaling
cascades [50]. In addition to having a high degree in the
protein interaction network of insulin signaling, AR was also
found to have the highest participation in the linear paths
from INSR to GLUT4 (Table 3). This is one of the promising
results of this study indicating critical nodes in the insulin
signaling governing glucose transportation.
4.Conclusions
There is a growing need for a comprehensive protein-protein
interaction network of insulin signaling, especially covering
its part on glucose metabolism with the aim to solve the
type2diabetesproblem.Here,weintegratedGOannotations
and interactome data for the reconstruction of a protein
interaction network of insulin signalling, considering the
relevance oftheproteinsaswell as theirinteractions. Starting
with 30 insulin signalling-related proteins, the proposed
method resulted in an interaction network of 3056 proteins
and 10,401 protein-protein interactions for human insulin
signaling. The linear paths transducing the signal from the
insulin receptor to the glucose transporter protein include
498 proteins with 2887 physical interactions and constitute
the network of signaling for glucose transportation. The key
components of the reconstructed network were identiﬁed as
bottlenecks and hubs since they are crucial for the signal
processing being central to many signaling paths and having
many neighboring proteins, respectively. The mechanisms
around these components, for example, directed interac-
tions, activation, or inhibition eﬀects in the reconstructed
insulin signaling network, are potential targets for further
analyses to gain insight on causes and results of type 2 dia-
betes. Additionally,DAXXprotein requires special care being
the unique protein that connects the ﬂowing information to
the GLUT4 protein. Finally, other putative insulin signaling6 Journal of Biomedicine and Biotechnology
Table 4: Graph properties of protein interaction networks.
Model Number of nodes Number of interactions Mean path length Diameter Reference
Insulin signaling 498 2887 2.9 5 Present study
EGFR signalling (Oda et al. 2005) 329 1795 4.7 11 [16]
DIP (S. cerevisiae) 4773 15444 5.0 13 [39]
DIP (S. cerevisiae) 5798 20098 4.9 12 [40]
DIP (D. melanogaster) 7451 22819 4.4 11 [39]
DIP (C. elegans) 2638 4030 4.8 14 [39]
DIP (H. pylori) 710 1420 4.1 9 [39]
DIP (H. sapiens) 1065 1369 6.8 21 [39]
DIP (E. coli) 553 761 5.5 16 [39]
DIP (M. musculus) 329 286 3.6 9 [39]
proteins having interaction with GLUT4 should be searched
to obtain a robust network. This large-scale protein-protein
interaction network allows us to consider any signaling node
within its global working mechanism which is required by
the holism perspective of systems biology approach.
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